logo-loader

Numinus Wellness lists on TSX, strengthens its medical expertise team with a focus on psychedelics

Published: 22:59 25 May 2020 EDT

Numinus Wellness Inc. (TSX-V: NUMI) CEO Payton Nyquvest tells Proactive the psychedelics health care company is strengthening its medical expertise team with the appointment of Dr. Gabor Maté, as a Member of the Numinus Clinical Advisory Council and Dr. Evan Wood as Chief Medical Officer.

Nyquvest says the Vancouver-based firm, which recently listed on the Toronto Stock Exchange, has a license through Health Canada to test, possess, buy and sell MDMA, psilocybin, psilocin, and DMT. It hopes to scale its model of operating stand-alone centers for patients with its health solutions in future acquisitions.

Proactive research analyst on Numinus Wellness' annual results

Proactive research analyst Daniel Appiah talks to Thomas Warner about his report on Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF), published to coincide with the release of the company's annual results. Appiah gives his take on how the company is currently performing and looks ahead to what its...

on 16/12/22